KTD-092

KTD-092, a DYRK1A inhibitor, exhibits an IC50 of 22 nM against human DYRK1A. It is applicable in research related to Down syndrome (DS), Alzheimer's disease (AD), autism spectrum disorder (ASD), diabetes, and other neurodegenerative diseases.

Product Specifications

Field of Research

Cell Biology, Signal Transduction

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP2-26644FR-0.1mL 0.1 mL

Mouse Monoclonal SSEA-4 Antibody (MC-813-70) [DyLight 680]

View Details

NBP2-70182JF646 0.1 mL

Mouse Monoclonal Annexin A11 Antibody (OTI1C6) [Janelia Fluor 646]

View Details

HY-RS00430 1 Set

AFF3 Human Pre-designed siRNA Set A

View Details

MBS1314019-01 0.02 mg (E-Coli)

Recombinant Mouse APOBEC1 complementation factor (A1cf)

View Details

MBS1314019-02 0.02 mg (Yeast)

Recombinant Mouse APOBEC1 complementation factor (A1cf)

View Details

MBS1314019-03 0.1 mg (E-Coli)

Recombinant Mouse APOBEC1 complementation factor (A1cf)

View Details